BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 16, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Cleveland Clinic Medical Innovation Summit: P4 Medicine concept divides healthcare into both wellness, disease segments

Oct. 29, 2014
By Omar Ford
CLEVELAND — If you were to ask Leroy Hood about what he thinks will happen to the current healthcare model in the future, more than likely the Institute for Systems Biology (Seattle) founder would say that patients will start to take more interest and ownership in their health and well being. Hood was the keynote speaker on Tuesday during the Cleveland Clinic's Medical Innovation Summit and discussed the role of medicine in the future, thusly impacted by the P4 Medicine model.
Read More

Cleveland Clinic Medical Innovation Summit: Myriad's Capone sees greater role for companion diagnostics

Oct. 29, 2014
By Omar Ford

Cleveland Clinic Medical Innovation Summit:: Innovation is more than a buzzword, it's lifeblood of healthcare industry

Oct. 28, 2014
By Omar Ford
Cleveland — Just what is the State of Innovation in Healthcare? Five panelists and a moderator discussed the topic during a session at Cleveland Clinic's Medical Innovation Summit on Monday afternoon. While many have prognositcated that when it comes to med-tech innovation, there is a great deal of doom and gloom on the horizon, that isn't necessarily the case and that prognostication could have dire implications for healthcare.
Read More

Rock Health founder discusses opportunities in mobile health

Oct. 28, 2014
By Omar Ford

Cleveland Clinic Innovation Summit: Cleveland Clinic gets 'personal' with cancer therapy during innovation summit

Oct. 27, 2014
By Omar Ford
CLEVELAND — Personalized medicine – particularly as it pertains to cancer treatments – is the focus of this year's Cleveland Clinic Medical Innovation Summit. The 12th annual summit titled, "This time It's Personal," will bring in more than 1,500 attendees to the Cleveland Convention Center.
Read More

MDD's Dignostics Extra

Oct. 24, 2014
By Omar Ford

NewCo on the Go: NuVascular forms in effort to get artificial blood vessels to market

Oct. 24, 2014
By Omar Ford

Say it with me... Google Glass is the next big thing in healthcare

Oct. 23, 2014
By Omar Ford
Physicians and surgeons are going to flock to Google Glass. That's my bold prediction and I'm sticking to it. I mean come on, just look at the impact the i-Pad has had on healthcare facilities across the country - sorry world. Now one of the main reasons Google Glass is going to make a strong impact, is because of it gives surgeons access to patient information and apps, at the benefit of freeing up the physician's hands. It's a common sense selling point, that I missed when I demo-ed the technology about a year ago. But what brought this fact...
Read More

Beta-O2 treats first patient in Bio-Artificial pancreas trial

Oct. 23, 2014
By Omar Ford

Veracyte developing new test to remove ambiguity from ILD screening

Oct. 21, 2014
By Omar Ford
Previous 1 2 … 73 74 75 76 77 78 79 80 81 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 15, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing